UVA Scientists Identify Calcium-Targeting Weakness in Glioblastoma

For decades, glioblastoma has resisted medicine's most aggressive tools, claiming lives within months or years of diagnosis. Researchers at the University of Virginia have now identified a precise structural vulnerability in how these tumors sustain themselves — a protein called SET EIP that governs calcium signaling within cancer cells. In naming this specific weakness, science has opened a door that was not previously visible, offering a new direction in the long human struggle against one of the brain's most merciless diseases.